Skip to main content
. 2023 Aug 26;14:5224. doi: 10.1038/s41467-023-41049-4

Fig. 1. Neutralization profiles of single variant exposure samples.

Fig. 1

Single variant exposure plasma samples were collected, either from unvaccinated individuals after first infection with ancestral virus (n = 5), alpha (n = 10), beta (n = 4), delta (n = 7), BA.1 (n = 16), BA.2 (n = 12), BA.5 (n = 1), or CK.2.1.1 (n = 2) variant or from two (BNT/BNT, n = 6) or three-dose (BNT/BNT/BNT, n = 6) vaccinated (ancestral) individuals. Titers of neutralizing antibodies against BA.2.75 variants (CB.1, BR.3, CH.1.1), BA.5 variants (BA.5.2.1, BE.1.1, BF.7, BQ.1.3, BQ.1.1, BQ.1.18), recombinant XBB variants (XBB.1, XBB.1.5.1), or recombinant XBF.3 for individual patients (circles) and geometric mean (red line) are shown. Titers below 16 were treated as negative (dotted line), and titers below 1 were set to 1. BNT = BNT162b2, IC50 titer = 50% neutralization titer.